Held at the Grand Hyatt Kauai Resort And Spa and located along the white sand beaches, this spectacular location is where you will earn 15 contact hours CE / CME over three days, 5 hours per day, of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/ CME credit.

Prefer not to travel or sit in the meeting space? Join us via live stream webcast & earn live CE/CME!

Speakers

**Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP**

Adult and family nurse practitioner and owner of a nurse practitioner owned and operated clinic in New Hampshire, recognized in Top Providers in New Hampshire 2020, Owner of Partners in Healthcare Education, Past President of NPACE. DR Wright has disclosures with Pfizer, Moderna, Merck, Sanofi, Seqirus,
Novavax, AbbVie and Pfizer; Idorsia; Exact Sciences; AstraZeneca.

Educational Sessions

Conference Credit

IN PERSON CONFERENCE REGISTRATION: Includes workshop attendance, handouts, breakfast or refreshments during the meetings and documentation of continuing education credit*.

Day 1: New Drug s Part 1, Obesity Case Studies, COPD , Fibromyalgia
At the completion of this activity, the participant will be able to:
New Drugs Part 1, 1.) Identify 10 – 20 new medications . 2) Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications. 3) Discuss updates related to labeling, indications, risks associated with various medications .Obesity Case Studies: 4) Discuss the health risks associated with obesity . 5) Identify the various behavioral modalities utilized to assist with weight loss . 6) Discuss pharmacologic strategies for weight stabilization or loss in the overweight or obese individual . COPD 7) Identify statistics regarding COPD. 8) Discuss the signs and symptoms of COPD. 9) Discuss treatment options for COPD . Fibromyalgia: 10)Identify new diagnostic criteria for fibromyalgia . 11) Discuss the various non-pharmacologic and pharmacologic treatments available for individuals with fibromyalgia .12) Review multimodal treatments based upon the evidence .
New Drug s Part 2, Pediatric Pharmacotherapeutics, COVID –Drug Interactions, CKD Treatment in Primary Care
At the completion of this activity, the participant will be able to:
New Drugs Part 2, 1) Identify 10 – 20 new medications 2) Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications. 3)Discuss updates related to labeling, indications, risks associated with various medications. Pediatric Pharmacotherapeutics: 4)Identify ways in which children are different than adults in terms of pharmacotherapeutics . 5) Discuss common pediatric prescribing errors. 6)Discuss strategies to prevent pediatric prescribing errors. 7) Identify medications with new pediatric approvals. COVID–Drug Interactions-8. Improve ability to identify disparity gaps in treatment, management, and drug interactions in outpatients with COVID-19. 9) Gain greater confidence in their ability to assess and manage outpatients with COVID-19 for drug interactions. 10) Enhance their understanding of the national COVID-19 Treatment Guidelines for outpatients with COVID-19. CKD Treatment in Primary Care 11) Detect and recognize CKD in patients with reduced kidney function, including in early stages of disease. 12) Implement screening for albuminuria in patients with diabetes in clinical practice to identify CKD as early as possible. 13) Initiate therapy with evidence-based therapies, including newer agents, for patients with CKD when indicated.
Antibiotic Update for Respiratory Infections, New Therapies for Resistant Hypertension , OA and RA Guidelines 2023 , Immunizations
At the completion of this activity, the participant will be able to:
Antibiotic Update: Respiratory Infections: 1) Identify statistics related to incidence/prevalence of various respiratory conditions. 2) Discuss the signs and symptoms of pneumonia, ABRS, AOM, AECB. 3) Discuss treatment pharmacologic options for the above conditions. New Therapies for Resistant Hypertension: 4) Discuss the definition of resistant hypertension . 5) Identify the work up for the patient with resistant hypertension. 6) Discuss the treatment options for patient with resistant hypertension . OA and RA Guidelines 2023: 7) Discuss the pathophysiology of osteoarthritis and rheumatoid arthritis. 8) Identify the non-pharmacologic and pharmacologic agents available for the treatment of osteoarthritis and RA. 9) Compare and contrast newer pharmacologic agents with older agents with regard to benefits, risks, side effects, and drug interactions. Immunizations: 10) Identify the 2024 recommended vaccinations and schedule for individuals across the lifespan. 11) Discuss the benefits and side effects of the various vaccines for individuals across the lifespan. 12) Discuss strategies to improve vaccine hesitancy.

LIVE STREAM WEBCAST REGISTRATION: Includes live conference streaming, access to online course materials and documentation of continuing education credit*.

*Pharmacists: Please ensure that we have your NABP# and date of birth on file. ACPE does not allow us to provide you with paper Statements of Credit. Should you need a paper statement of credit, you can access that information via CPE Monitor. All other professionals: An applicable paper Statement of Credit will be issued upon receipt of your post-conference paperwork. Zoom Requires: An internet connection – broadband wired or wireless (3G or 4G/LTE) For More info: https://support.zoom.us/hc/en-us/ articles/201362023-Zoom-system-requirements-Windows-macOS-Linux

REQUIREMENTS FOR CREDIT: Credit is dependent on verification of conference attendance by on-time check-in at each session and ULS receipt of completed evaluations. Credit is determined based on actual attendance on a per session basis, no partial credit is awarded. Note: Approximately one 15 minute break per 2.5 hours. Credited hours do not include breaks.

TARGET AUDIENCE/ ACCREDITATION

PHYSICIANS: AAFP approval is in progress. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session: 15.00 In-Person, Live (could include online) AAFP Prescribed Credits - Therapeutic Update 2021 Kauai Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA).

CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.

PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.

CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.

NURSE PRACTITIONERS/ NURSES: This course provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .

OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approv

Session	Contact Hours	ACPE UAN	Activity
Session 1	5	0741-0000-24-0024-L08-P	APPLICATION
Session 2	5	0741-0000-24-0025-L08-P	APPLICATION
Session 3	5	0741-0000-24-0026-L08-P	KNOWLEDGE

Conference Registration

Option	3 Day Fee	2 Day Fee	1 Day Fee
Live Stream	$550	$398	$199
Discounted Advanced Registration Expires September 8, 2024	$750	n/a	n/a
Regular Registration	$799	n/a	n/a
Advanced Registration NOT Staying at Hyatt	$950	n/a	n/a
Regular Registration NOT Staying at Hyatt	$999	n/a	n/a

Hotel Information

Standard ViewKing PartialOcean View King Deluxe OceanView King	$419/night—basedonavailability $445/night—basedonavailability $485/night—basedonavailability
Address	Grand Hyatt Kauai Resort & Spa 1571 PoipuRd Koloa,HI96756
Online Reservations	https://www.hyatt.com/en-US/group-booking/KAUAI/G-UNIV
Phone Reservations	1-877-803-7534
ULS Group Code	G-UNIV or UniversityLearningSystems
ULS Group Expiration Date	September8,2024
Hotel Taxes	17.96%
Discounted ResortFee	$30.00/night
Parking Fee	Self Free,Valet $TBD/day
Attrition Fee if not staying at ULS hotel.	$200

Attrition Surcharge

If you don't make reservations and stay at the hotel where University Learning Systems has reserved a block of rooms, you must add the attrition surcharge to the conference fee. Staying at hotel with an offer other than the ULS Group Code such as through a third party booking, still requires payment of the Attrition Surcharge. 2023/2024 Hotel Attrition Surcharge: $200

ULS will verify all rooming/cabin information with the hotel /travel agent and the hotel /travel agent has the right to release pertinent information to ULS for all attendees. No credit will be reported until the Attrition Surcharge is satisfied.

We apologize for any inconvenience. Unfortunately we have recently experienced a rash of attendees not utilizing the ULS designated hotel or travel agent causing ULS to incur significant penalties.